Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer

R Assidicky, UM Tokat, IO Tarman, O Saatci… - Breast cancer research …, 2022 - Springer
Purpose Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast
cancer that is frequently treated with chemotherapy. However, many patients exhibit either …

The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools

M Verma - Advances in Cancer Biomarkers: From biochemistry to …, 2015 - Springer
Epigenetics plays a key role in cancer development. Genetics alone cannot explain sporadic
cancer and cancer development in individuals with no family history or a weak family history …

The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: A systematic review

N Iranshahi, P Zafari, KH Yari… - Cellular and Molecular …, 2016 - cellmolbiol.org
Breast cancer, with a lifelong risk of one in nine, is the most common cancer among women.
In Iran, breast cancer is one of the growing and important women's health problems. Several …

Validation of DNA promoter hypermethylation biomarkers in breast cancer—a short report

JS De Groot, X Pan, J Meeldijk, E Van Der Wall… - Cellular oncology, 2014 - Springer
Purpose DNA promoter hypermethylation of tumor suppressor genes is known to occur early
in cancer development, including breast cancer. To improve early breast cancer detection …

Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer

K Misawa, M Mima, Y Satoshi, Y Misawa, A Imai… - Scientific reports, 2020 - nature.com
Pathological staging and histological grading systems are useful, but imperfect, predictors of
recurrence in head and neck squamous cell carcinoma (HNSCC). Aberrant promoter …

[HTML][HTML] GHSR DNA hypermethylation is a common epigenetic alteration of high diagnostic value in a broad spectrum of cancers

EA Moskalev, P Jandaghi, M Fallah, M Manoochehri… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Identification of a single molecular trait that is determinant of common malignancies may
serve as a powerful diagnostic supplement to cancer type-specific markers. Here, we report …

GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond

M Amini, K Foroughi, F Talebi… - Journal of Cellular …, 2019 - Wiley Online Library
Aberrations of DNA methylation are early events in the development of tumors. In this study,
we investigated the DNA methylation status of growth hormone secretagogue receptor …

Investigation of GHSR and GHRL Methylation in Colorectal Cancer

F Coppedè, A Stoccoro, A Lazzarotti, R Spisni… - …, 2018 - Taylor & Francis
Aim: To investigate GHSR and GHRL methylation in 73 pairs of colorectal cancer (CRC)
tissues and healthy adjacent mucosa. Methods: Methylation was assessed with methylation …

Nuclear colocalization and complex formation of insulin with retinoblastoma protein in HepG2 human hepatoma cells

RT Radulescu, ED Doklea, K Kehe… - Journal of …, 2000 - joe.bioscientifica.com
Genetic variations in ovulation rate which occur in different breeds of sheep provide useful
models to explore the mechanisms regulating the development of antral follicles. The …

GHSR hypermethylation: a promising pan-cancer marker

P Jandaghi, JD Hoheisel, Y Riazalhosseini - Cell Cycle, 2015 - Taylor & Francis
The advent of high-throughput technologies such as microarrays, global gene knockout, and
next generation sequencing (NGS) has revolutionized the field of molecular oncology. Large …